Evaxion A/S (EVAX)
NasdaqCM: EVAX
· リアルタイム株価 · USD
3.15
+0.05 (1.61%)
終値時点: Aug 18, 2026, 3:59 PM
Evaxion A/S (EVAX) Stock Price, Analysis & Data
1.61% (1D)
EVAXについて
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are...
企業情報の全文決算サプライズ
Evaxion A/SはMay 7, 2026に四半期決算を発表しました:
2ページ中1ページ
